Tierarztliche Praxis. Ausgabe G, Grosstiere/Nutztiere2026; 54(3); 190-198; doi: 10.1055/a-2854-4109

[New drugs for horses and production animals in 2025].

Kamutzki, CJ
·
Lüttig, A
·
Emmerich, IU

Abstract: In 2025, no novel pharmaceutical agents for horses and farm animals were introduced to the German veterinary drug market; however, the use of 2 existing active ingredients was expanded to include additional animal species. A dexamethasone preparation is now approved for use in goats, and a new product containing sodium salicylate for chickens was introduced. Oxalic acid dihydrate is now available as an impregnated strip for contact treatment. In the field of immunological veterinary medicines, a vaccine against epizootic hemorrhagic disease virus in cattle was approved for the first time. In addition, all 3 vaccines already available against bluetongue virus in cattle and sheep received approval. For chickens, there is a new trivalent combination product against Newcastle disease, infectious laryngotracheitis, and infectious bursitis, as well as a vaccine with an additional serotype of avian reovirus. A new method of administration enables an additional use for a vaccine against rotaviruses, coronaviruses, and (subcutaneous) in cattle. In addition, new package sizes of a vaccine for calves against bovine respiratory syncytial virus and bovine parainfluenza 3 virus, as well as a vaccine for chickens against avian salmonellosis have been introduced to the market. Im Jahr 2025 kamen keine neuen Wirkstoffe für Pferde und landwirtschaftliche Nutztiere auf den deutschen Tierarzneimittelmarkt, jedoch wurden 2 bestehende Wirkstoffe auf zusätzliche Tierarten erweitert. Ein Dexamethason-Präparat ist nun bei Ziegen anwendbar und ein neues Natriumsalicylat-haltiges Produkt für Hühner wurde eingeführt. Oxalsäuredihydrat ist nun als imprägnierter Streifen zur Kontaktbehandlung verfügbar. Bei den immunologischen Tierarzneimitteln wurde erstmals ein Impfstoff gegen das Epizootische Hämorrhagie-Virus beim Rind zugelassen. Außerdem erhielten alle 3 bisher schon verfügbaren Impfstoffe gegen das Blauzungen-Virus bei Rind und Schaf eine Zulassung. Für Hühner gibt es ein neues trivalentes Kombinationspräparat gegen die Newcastle-Disease, die Infektiöse Laryngotracheitis und Infektiöse Bursitis sowie einen Impfstoff mit einem weiteren Serotypen des Aviären Reovirus. Eine neue Applikationsart ermöglicht eine weitere Anwendung für einen Impfstoff gegen Rota- und Coronaviren sowie (subkutan) beim Rind. Zusätzlich wurden neue Packungsgrößen eines Impfstoffs für Kälber gegen das Bovine Respiratorische Synzytialvirus sowie das Bovine Parainfluenza 3-Virus und eines Impfstoffs für Hühner gegen die Aviäre Salmonellose in den Verkehr gebracht.

Get Full Text

Publication Date: 2026-07-01 PubMed ID: 42385734DOI: 10.1055/a-2854-4109Google Scholar: Lookup

The Equine Research Bank provides access to a large database of publicly available scientific literature. Inclusion in the Research Bank does not imply endorsement of study methods or findings by Mad Barn.

Facebook X LinkedIn Email Copy

Summary
Cite This
Publication
Affiliations
MeSH
Conflict of Interest
Citations

English Abstract
Journal Article

Summary

This research summary has been generated with artificial intelligence and may contain errors and omissions. Refer to the original study to confirm details provided. Submit correction.

Overview

In 2025, no new pharmaceutical substances for horses and farm animals were introduced to the German veterinary market.
However, existing drugs expanded their use to include new animal species, and several new formulations and vaccines were approved.

New and Expanded Pharmaceutical Approvals

Dexamethasone:
- Previously approved for certain uses, now additionally authorized for use in goats.
Sodium Salicylate:
- A new product formulation containing sodium salicylate was introduced for chickens.
Oxalic Acid Dihydrate:
- Available as an impregnated strip for contact treatment, providing a new method of application.

Advances in Immunological Veterinary Medicines (Vaccines)

Epizootic Hemorrhagic Disease Virus (EHDV) Vaccine:
- For the first time, a vaccine against EHDV was approved for cattle, targeting a significant infectious disease.
Bluetongue Virus Vaccines:
- All three existing vaccines for bluetongue virus in cattle and sheep received official approval, ensuring continued disease control.
Chicken Vaccines:
- A new trivalent combination vaccine was introduced, protecting against:
  - Newcastle disease
  - Infectious laryngotracheitis
  - Infectious bursitis
- A novel vaccine including an additional serotype of avian reovirus was approved, broadening immunity coverage.
- New vaccine against avian salmonellosis was made available, improving disease prevention in poultry.
Cattle Vaccines:
- A vaccine targeting rota- and coronaviruses was enhanced with a new subcutaneous administration route, allowing additional modes of use.
- New package sizes were introduced for vaccines protecting calves against:
  - Bovine respiratory syncytial virus (BRSV)
  - Bovine parainfluenza 3 virus (PI3)

Summary

No new substances were launched, but existing drugs expanded to new species and innovative formulations emerged.
Vaccination options improved significantly, with new vaccines approved for cattle and poultry, enhancing protection against multiple viral diseases.
New administration methods and packaging options also support better usability and disease management in farm animals.

Cite This Article

APA

Kamutzki CJ, Lüttig A, Emmerich IU. (2026). [New drugs for horses and production animals in 2025]. Tierarztl Prax Ausg G Grosstiere Nutztiere, 54(3), 190-198. https://doi.org/10.1055/a-2854-4109